Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Meningioma × Mifepristone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 8 Leiomyoma 7 Triple Negative Breast Neoplasms 3 Prostatic Neoplasms 3 Pituitary Diseases 3 Pituitary ACTH Hypersecretion 3 Cushing Syndrome 3 ACTH Syndrome, Ectopic 3 Ovarian Neoplasms 2 Hirsutism 2 Fallopian Tube Neoplasms 2 Choristoma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Adrenal Cortex Neoplasms 2 Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2 1 Uterine Hemorrhage 1 Sarcoma 1 Neoplasms 1 Meningioma 1 Gulf War Illness 1 Carcinoma, Transitional Cell 1 Carcinoma, Intraductal, Noninfiltrating 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Female 1

Interventions

Magnetic Resonance Spectroscopy 14 Hydroxyurea 7 Everolimus 7 lutetium Lu 177 dotatate 6 gallium Ga 68 dotatate 6 Radiosurgery 6 Proton Therapy 6 Specimen Handling 5 Bevacizumab 5 pembrolizumab 4 Surveys and Questionnaires 4 Radiotherapy 4 Imatinib Mesylate 4 Cyclophosphamide 4 abemaciclib 3 Tranexamic Acid 3 Temozolomide 3 Surgical Procedures, Operative 3 Sunitinib 3 Radiotherapy, Intensity-Modulated 3 Observation 3 Nivolumab 3 Ga(III)-DOTATOC 3 90Y-octreotide, DOTA-Tyr(3)- 3 trametinib 2 fludarabine 2 arginyllysine 2 aldesleukin 2 Yoga 2 Whole Body Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03015701 2019-12-23

S9005 Mifepristone in Meningioma

SWOG Cancer Research Network

Phase 3 Completed

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡